Alphatec Holdings (ATEC) Cash from Investing Activities (2010 - 2026)
Alphatec Holdings (ATEC) reported Cash from Investing Activities of -$19.9 million for Q1 2026, down 71.32% on a YoY basis from -$69.4 million in Q1 2025, and down 26.43% sequentially from -$15.7 million in Q4 2025.
Alphatec Holdings (ATEC) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Alphatec Holdings (ATEC) has 17 years of Cash from Investing Activities data on file, last reported at -$19.9 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities fell 71.32% year-over-year to -$19.9 million; the trailing twelve-month figure through Mar 2026 stood at -$61.7 million (up 13.27% YoY), and the FY2025 full-year result was -$53.4 million, up 42.65% from the prior year.
- Cash from Investing Activities slipped to -$19.9 million in Q1 2026, from -$15.7 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$3.7 million in Q4 2024 to a low of -$75.6 million in Q2 2023.
- A 5-year average of -$21.6 million and a median of -$15.7 million in 2025 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities tumbled 424.38% in 2023 and surged 86.72% in 2024, its largest moves.
- Tracing ATEC's Cash from Investing Activities over 5 years: stood at -$14.8 million in 2022, then sank by 90.18% to -$28.2 million in 2023, then surged by 86.72% to -$3.7 million in 2024, then sank by 320.05% to -$15.7 million in 2025, then retreated by 26.43% to -$19.9 million in 2026.
- Business Quant data shows ATEC's Cash from Investing Activities at -$19.9 million in Q1 2026, -$15.7 million in Q4 2025, and -$13.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.21 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.52 Bn | 125.64 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 108.06 Bn | 98.84 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 68.04 Bn | 66.59 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | -298.50 Mn |
| 8 | Smith & Nephew | 26.88 Bn | 26.30 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Alphatec Holdings | 1.35 Bn | 1.21 Bn | 136.48 Mn | -19.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.89 Mn |
| Mar 31, 2026 | -19.89 Mn |
| Dec 31, 2025 | -15.74 Mn |
| Dec 31, 2025 | -15.74 Mn |
| Sep 30, 2025 | -13.89 Mn |
| Sep 30, 2025 | -13.89 Mn |
| Jun 30, 2025 | -12.17 Mn |
| Jun 30, 2025 | -12.17 Mn |
| Mar 31, 2025 | -11.61 Mn |
| Mar 31, 2025 | -11.61 Mn |
| Dec 31, 2024 | -3.75 Mn |
| Dec 31, 2024 | -3.75 Mn |
| Sep 30, 2024 | -19.88 Mn |
| Sep 30, 2024 | -19.88 Mn |
| Jun 30, 2024 | -35.89 Mn |
| Jun 30, 2024 | -35.89 Mn |
| Mar 31, 2024 | -33.62 Mn |
| Mar 31, 2024 | -33.62 Mn |
| Dec 31, 2023 | -28.21 Mn |
| Dec 31, 2023 | -28.21 Mn |